Science ❯ Biology ❯ Immunology
Rheumatoid Arthritis T Lymphocytes Type 1 Diabetes Pathogenesis IPEX Syndrome T Cell Function Foxp3 Gene Cytokines Clinical Trials Peripheral Immune Tolerance T Cells Regulatory T Cells
An adaptive trial in newly diagnosed patients identified 0.5 mg/kg as the minimum effective dose with fewer adverse events than a higher dose.
